Best Value Determination Doesn't Comply with High Value, Sole-Source IDIQ Requirements
Client Alert | less than 1 min read | 04.22.13
In the first published decision to interpret the selection criteria applicable to high value, sole-source, IDIQ contract awards, in CW Gov't Travel, Inc. v. U.S. the Court of Federal Claims made clear that the government is required to determine, per FAR 16.504(c)(1)(ii)(D), that the awardee is the only source that is qualified and capable of performing the work at a reasonable price before awarding a sole-source, IDIQ contract over $103 million. Because the government had based its award decision on best value criteria instead, the CFC ruled for the protester.
Insights
Client Alert | 11 min read | 04.27.26
EU Pharma Package: Access Conditionalities and Shortage Measures Compromise Proposal
In our seventh alert in this EU Pharma Package Series, we provided an analysis of the increasing focus on shortages of medicinal products in the EU and the prevention and mitigation measures as proposed by the EU institutions.
Client Alert | 3 min read | 04.24.26
Client Alert | 2 min read | 04.24.26
Client Alert | 4 min read | 04.23.26
Bipartisan Coalition of State AGs Backs Federal PBM Transparency Rule
